Market capitalization | €726.87m |
Enterprise Value | €1.50b |
P/E (TTM) P/E ratio | 28.90 |
EV/FCF (TTM) EV/FCF | 12.22 |
EV/Sales (TTM) EV/Sales | 1.31 |
P/S ratio (TTM) P/S ratio | 0.63 |
P/B ratio (TTM) P/B ratio | 1.15 |
Dividend yield | 7.12% |
Last dividend (FY23) | €1.00 |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
9 Analysts have issued a CompuGroup Medical forecast:
9 Analysts have issued a CompuGroup Medical forecast:
Sep '24 |
+/-
%
|
||
Revenue | 1,152 1,152 |
5%
5%
|
|
Gross Profit | 262 262 |
24%
24%
|
|
EBITDA | 239 239 |
12%
12%
|
EBIT (Operating Income) EBIT | 120 120 |
26%
26%
|
Net Profit | 25 25 |
67%
67%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
CompuGroup Medical SE & Co. KGaA engages in the provision of e-Health solutions. Its software products are designed to support all medical and organizational activities in doctor’s office, pharmacies, laboratories and hospitals. The company operates through the following segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Health Connectivity Services (HCS). The AIS segment focuses on practice management software and electronic medical records for office-based physicians, dentists, medical care centers and physician's networks. The PCS segment focuses on integrated clinical, administrative and financial software applications for retail pharmacies. The HIS segment focuses on clinical and administrative solutions for the inpatient sector, where health services are provided over a prolonged period of time through highly specialized, secondary care institutions. The HCS segment on customers within the healthcare sector that are outside the healthcare providers. The company was founded by Frank Gotthardt in 1987 and is headquartered in Koblenz, Germany.
Head office | Germany |
CEO | Daniel Gotthardt |
Employees | 9,199 |
Founded | 1987 |
Website | www.cgm.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.